UK government confirms support for continued acceptance of CE-marked medical devices in Great Britain on a long-term basis.
Sovereign AI and trusted research environments are quietly reshaping how pharma companies access and analyze data.
The FDA retired the Chief Information Officer title, but Sanjay Sahoo moved to temporarily lead the new Office of Mission ...
The PD-1 blocking immunotherapy is the first approved treatment in a subset of rectal cancer patients, building on one ...
Women’s sports organizations support their athletes’ health and fitness to extend their careers, but research is limited on ...
As China’s new cosmetics safety standard starts a compliance clock for brands, cosmetic chemist Kelly Dobos explains in an ...
At recent CRN conference, USANA chief scientific officer Kathryn Armstrong says the firm uses six-point check list to ...
Data from the ARC-20 platform study drive optimism for the Phase III program as the company touts favorable efficacy numbers ...
A white paper on “Digitally Derived Measures” stresses that the process of incorporating them into clinical trials must start ...
Oncology leaders say they’ve learned how to better design and differentiate newer versions of antibody-drug conjugates ...
EMA supports dropping the prescription requirement for Mundipharma’s Nyxoid, but each EU state will decide where it is sold.
New final guidance on prescription drug use-related software makes clear that without evidence of improved clinical outcomes, labeling must state the software is not necessary for safe and effective ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results